| Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the … MJ Rybak, J Le, TP Lodise, DP Levine, JS Bradley, C Liu, BA Mueller, ... American Journal of Health-System Pharmacy 77 (11), 835-864, 2020 | 1036 | 2020 |
| Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) GR Matzke, GR Aronoff, AJ Atkinson Jr, WM Bennett, BS Decker, ... Kidney international 80 (11), 1122-1137, 2011 | 507 | 2011 |
| A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. WR Clark, BA Mueller, KJ Alaka, WL Macias Journal of The American Society of Nephrology 4 (7), 1413-1420, 1994 | 192 | 1994 |
| Drug-associated renal dysfunction SS Taber, BA Mueller Critical care clinics 22 (2), 357-374, 2006 | 174 | 2006 |
| Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model WR Clark, JK Leypoldt, LW Henderson, BA Mueller, MK Scott, EF Vonesh Journal of the American Society of Nephrology 10 (3), 601-609, 1999 | 160 | 1999 |
| Impact of the nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure WL Macias, KJ Alaka, MH Murphy, ME Miller, WR Clark, BA Mueller Journal of Parenteral and Enteral Nutrition 20 (1), 56-62, 1996 | 157 | 1996 |
| Extracorporeal therapy requirements for patients with acute renal failure. WR Clark, BA Mueller, MA Kraus, WL Macias Journal of the American Society of Nephrology 8 (5), 804-812, 1997 | 144 | 1997 |
| Noni juice (Morinda citrifolia): hidden potential for hyperkalemia? BA Mueller, MK Scott, KM Sowinski, KA Prag American Journal of Kidney Diseases 35 (2), 310-312, 2000 | 139 | 2000 |
| Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure WL Macias, BA Mueller, SK Scarim, M Robinson, DW Rudy American journal of kidney diseases 18 (4), 451-458, 1991 | 123 | 1991 |
| Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin MB Kays, BR Overholser, BA Mueller, SM Moe, KM Sowinski American journal of kidney diseases 42 (6), 1253-1259, 2003 | 117 | 2003 |
| Antibiotic dosing in critically ill patients with acute kidney injury RF Eyler, BA Mueller Nature Reviews Nephrology 7 (4), 226-235, 2011 | 112 | 2011 |
| Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance WL Macias, BA Mueller, SK Scarim Clinical Pharmacology & Therapeutics 50 (6), 688-694, 1991 | 111 | 1991 |
| Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin BA Mueller, DG Brierton, SR Abel, L Bowman Antimicrobial agents and chemotherapy 38 (9), 2101-2105, 1994 | 105 | 1994 |
| Renal dosing of antibiotics: are we jumping the gun? RL Crass, KA Rodvold, BA Mueller, MP Pai Clinical infectious diseases 68 (9), 1596-1602, 2019 | 102 | 2019 |
| Clinical review: drug metabolism and nonrenal clearance in acute kidney injury AM Vilay, MD Churchwell, BA Mueller Critical care 12, 1-9, 2008 | 100 | 2008 |
| Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy IF Btaiche, RA Mohammad, C Alaniz, BA Mueller Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (5 …, 2008 | 98 | 2008 |
| Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis AM Vilay, M Grio, DD DePestel, KM Sowinski, L Gao, M Heung, ... Critical care medicine 39 (1), 19-25, 2011 | 96 | 2011 |
| Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline … MJ Rybak, J Le, T Lodise, D Levine, J Bradley, C Liu, B Mueller, M Pai, ... Journal of the Pediatric Infectious Diseases Society 9 (3), 281-284, 2020 | 94 | 2020 |
| Higher renal replacement therapy dose delivery influences on drug therapy BA Mueller, DA Pasko, KM Sowinski Artificial organs 27 (9), 808-814, 2003 | 88 | 2003 |
| How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy? JA Jamal, BA Mueller, GYS Choi, J Lipman, JA Roberts Diagnostic microbiology and infectious disease 82 (1), 92-103, 2015 | 84 | 2015 |
Susan J. LewisUniversity of Findlay College of Pharmacy在 findlay.edu 的电子邮件经过验证
